Clinical Trials Directory

Trials / Completed

CompletedNCT04686838

REmote Assessment and Dynamic Response Intervention II

READyR-II: Dynamic Tailoring Phase for a Remote Assessment and Dynamic Response Intervention to Support Couples in Planning for Changing Dementia Care Needs

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of the READyR II Study is to test a dynamic tailoring phase of a remote assessment for changing dementia-related care needs.

Detailed description

Unmet dementia-related care needs are highly prevalent, and are detrimental to the care dyad's (person with dementia and their family care partner) health, safety, mortality, and likelihood of nursing home placement. READyR II tests a dynamic tailoring phase of an intervention program that was previously developed to remotely assess dementia-related care needs using digital data on behavioral patterns (from sensors and wearables) in the home. READyR II follows participants who have completed READyR for a total of six months in order to detect anomalies in activity patterns that may indicate new and unforeseen care needs. People who voluntarily decide to participate in this follow-up intervention study will be asked to continue participating with the in-home monitoring sensor platform, complete weekly questionnaires, and receive regular follow-up telephone calls from the study team.

Conditions

Interventions

TypeNameDescription
BEHAVIORALREADyR II: AContinuous monitoring for anomaly detection and contact phone call when a potential change in care needs is indicated by an anomaly.
BEHAVIORALREADyR II: BSensors will remain in the home but anomaly detection analysis will not be performed and contact phone calls will be at regular intervals without dynamic tailoring content.

Timeline

Start date
2021-07-01
Primary completion
2022-11-17
Completion
2022-11-25
First posted
2020-12-29
Last updated
2023-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04686838. Inclusion in this directory is not an endorsement.